Athira Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Athira Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About ATHA

LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. 

CEO
Mark J. Litton, PhD, MBA
CEOMark J. Litton, PhD, MBA
Employees
19
Employees19
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
2011
Founded2011
Employees
19
Employees19

ATHA Key Statistics

Market cap
34.00M
Market cap34.00M
Price-Earnings ratio
-0.34
Price-Earnings ratio-0.34
Dividend yield
Dividend yield
Average volume
29.71K
Average volume29.71K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.21
52 Week high$14.21
52 Week low
$2.85
52 Week low$2.85

Stock Snapshot

With a market cap of 34M, Athira Pharma(ATHA) trades at $3.62. The stock has a price-to-earnings ratio of -0.34.

On 2026-06-07, Athira Pharma(ATHA) stock opened at —, reached a high of —, and a low of —.

Athira Pharma(ATHA) shares are trading with a volume of 0, against a daily average of 29.71K.

In the last year, Athira Pharma(ATHA) shares hit a 52-week high of $14.21 and a 52-week low of $2.85.

In the last year, Athira Pharma(ATHA) shares hit a 52-week high of $14.21 and a 52-week low of $2.85.

People also own

Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.